Cargando…
Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
INTRODUCTION: The clinical relevance of Achromobacter xylosoxidans infection in cystic fibrosis (CF) remains controversial. This emerging agent in CF has been associated with increased lung inflammation, more frequent exacerbations and more severe lung disease. We describe a pair of CF siblings chro...
Autores principales: | Firmida, Mônica Cássia, Marques, Elizabeth Andrade, Leão, Robson Souza, Pereira, Rosana Helena Vicente, Rodrigues, Elenice Rosa Aguiar, Albano, Rodolpho Mattos, Folescu, Tania Wrobel, Bernardo, Vagner, Daltro, Pedro, Capone, Domenico, Lopes, Agnaldo José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256675/ https://www.ncbi.nlm.nih.gov/pubmed/28138423 http://dx.doi.org/10.1016/j.rmcr.2017.01.005 |
Ejemplares similares
-
Clinical impact of Achromobacter xylosoxidans
colonization/infection in patients with cystic fibrosis
por: Firmida, M.C., et al.
Publicado: (2016) -
Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre
por: da Costa Ferreira Leite, Cassiana, et al.
Publicado: (2017) -
Draft genome sequences of four Achromobacter ruhlandii
strains isolated from cystic fibrosis patients
por: Rodrigues, Elenice RA, et al.
Publicado: (2016) -
Osteomyelitis caused by Achromobacter xylosoxidans
por: Shinha, Takashi, et al.
Publicado: (2015) -
Pacemaker Lead Endocarditis Caused by Achromobacter xylosoxidans
por: Ahn, Youngkeun, et al.
Publicado: (2004)